Institution profile

University Of Iowa

Rank #62 · 15 unique linked submissions.

People

Top contributors

Poster Poster Program
The Commissioning and Validation of Gpumcd for an Elekta Versa HD Linear Accelerator In the Elekta One Treatment Planning System

GPUMCD, a GPU-accelerated Monte Carlo dose calculation algorithm, was recently released for clinical implementation in the Elekta One Treatment Planning System (v6.2.3, EOP) for c-arm Elekta linear accelerators (linac). The purpose of this work was to validat...

Blake R. Smith, PhD, MSDaniel E. Hyer, PhDJun-Hsuang JenSamuel D. Rusu, MSGrace Hutchinson, MS
Therapy Physics
Poster Poster Program
Integration of Functional Imaging to Guide Adaptive Treatment Planning for Lung SBRT

Hyperpolarized Xenon imaging is a recent FDA-approved MRI technique that can measure physiological changes in ventilation, membrane uptake, and red blood cell transfer of gas throughout the lung. The scope of this work is to demonstrate the feasibility of int...

Sean Bedilion Fain, PhDMariah Costa, PhDMarrissa McIntosh, PhDRiley Meyer, BS
Therapy Physics
Paper Proffered Program
Patient-Informed Lesion Insertion Framework for Realistic Quantitative Evaluation In PET Imaging

Accurate quantitative assessment in positron emission tomography (PET) is essential for reliable lesion characterization and therapy response evaluation. Quantitative accuracy is conventionally investigated using physical phantoms or numerical simulations; ho...

Sinan AkayAditya RavindraAhmad ShariftabriziFarooq Umar
Radiopharmaceuticals, Theranostics, and Nuclear Medicine
Paper Proffered Program
Multi-Lesion PET Radiomic Phenotyping and Aggregation for Prognostication In Diffuse Large B-cell Lymphoma Treated with CAR-T Therapy

To develop and evaluate a radiomic phenotyping and multi-lesion aggregation scheme to derive patient-level biomarkers for identifying progressive disease and predicting time-to-progression (TTP) in diffuse large B-cell lymphoma (DLBCL).

Ahmad ShariftabriziAditya RavindraFarooq UmarSinan Akay
Radiopharmaceuticals, Theranostics, and Nuclear Medicine